<?xml version='1.0' encoding='utf-8'?>
<document id="16027403"><sentence text="Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics."><entity charOffset="10-22" id="DDI-PubMed.16027403.s1.e0" text="rosuvastatin" /></sentence><sentence text="The effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics was assessed in 2 trials"><entity charOffset="14-26" id="DDI-PubMed.16027403.s2.e0" text="rosuvastatin" /></sentence><sentence text=" In trial A (a randomized, double-blind, 2-period crossover study), 18 healthy volunteers were given rosuvastatin 40 mg or placebo on demand (o"><entity charOffset="101-113" id="DDI-PubMed.16027403.s3.e0" text="rosuvastatin" /></sentence><sentence text="d" /><sentence text=") for 10 days with 1 dose of warfarin 25 mg on day 7" /><sentence text=" In trial B (an open-label, 2-period study), 7 patients receiving warfarin therapy with stable international normalized ratio values between 2 and 3 were coadministered rosuvastatin 10 mg o"><entity charOffset="169-181" id="DDI-PubMed.16027403.s6.e0" text="rosuvastatin" /></sentence><sentence text="d" /><sentence text=" for up to 14 days, which increased to rosuvastatin 80 mg if the international normalized ratio values were &lt;3 at the end of this period" /><sentence text=" The results indicated that rosuvastatin can enhance the anticoagulant effect of warfarin"><entity charOffset="28-40" id="DDI-PubMed.16027403.s9.e0" text="rosuvastatin" /><entity charOffset="81-89" id="DDI-PubMed.16027403.s9.e1" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.16027403.s9.e0" e2="DDI-PubMed.16027403.s9.e0" /><pair ddi="false" e1="DDI-PubMed.16027403.s9.e0" e2="DDI-PubMed.16027403.s9.e1" /></sentence><sentence text=" The mechanism of this drug-drug interaction is unknown" /><sentence text=" Rosuvastatin had no effect on the total plasma concentrations of the warfarin enantiomers, but the free plasma fractions of the enantiomers were not measured"><entity charOffset="1-13" id="DDI-PubMed.16027403.s11.e0" text="Rosuvastatin" /></sentence><sentence text=" Appropriate monitoring of the international normalized ratio is indicated when this drug combination is coadministered" /><sentence text="" /></document>